FDA.reportPublic FDA data

WELL AT WALGREENS PINK GRAPEFRUIT

Manufacturer
WALGREEN COMPANY | APOLLO HEALTH AND BEAUTY CARE
Effective date
2015-12-09
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:44:19

Label at a glance#

ProductWELL AT WALGREENS PINK GRAPEFRUIT
Active ingredientSALICYLIC ACID
Label structure8 sections

Indications and uses

for the treatment of acne.

Dosage and administration

use twice a day wet face apply to hands with some water and work into lather gently massage face and rinse thoroughly

Storage and handling

store between 20°C - 25°C (68 - 77°F)

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Uses

INDICATIONS & USAGE SECTION

for the treatment of acne.

Warnings

WARNINGS SECTION

For external use only

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

using other topical acne medications at the same time or immediately following use of this product. This may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless otherwise directed by a doctor.

When using this product

OTC - WHEN USING SECTION

avoid contact with eyes. If contact occurs, rinse thoroughly with water.

Stop using this product and ask a doctor if

OTC - STOP USE SECTION

irritation or redness develops and lasts

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • use twice a day
  • wet face
  • apply to hands with some water and work into lather
  • gently massage face and rinse thoroughly

Other information

STORAGE AND HANDLING SECTION

store between 20°C - 25°C (68 - 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water (Aqua), Sodium C14-16 Olefin Sulfonate, Glycerin, Cocamidopropyl Betaine, Acrylates Copolymer, Sodium Chloride, Hydrogenated Castor Oil, Carrageenan, C12-15 Alkyl Lactate, Disodium EDTA, Cocamidopropyl PG-Dimonium Chloride Phosphate, Citrus Grandis (Grapefruit) Fruit Extract, Polyquaternium-7, Camellia Sinesis Leaf Extract, Ascorbyl Palmitate, Neopentyl Glycol Dicaprylate/Dicaprate, Anthemis Nobilis Flower Extract, Polysorbate 20, Polyvinyl Alcohol, Propylene Glycol, Butylene Glycol, Sodium Benzotriazolyl Butylphenol Sulfonate, Agar, Mica, Titanium Dioxide (CI 77891), Sodium Hydroxide, Red 30 (CI 73360), Red 40 (CI 16035), Ext. Violet 2 (CI 60730), Fragrance (Parfum).

Questions/comments?

OTC - QUESTIONS SECTION

1-800-925-4733

Label Copy

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of the labelImage of the label

Image of the packetteImage of the packette

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
562600salicylic acid 2 % Medicated Liquid SoapPSN1
562600salicylic acid 20 MG/ML Medicated Liquid SoapSCD1
562600salicylic acid 2 % Facial Cleanser TonerSY1
562600salicylic acid 2 % Facial ScrubSY1
562600salicylic acid 2 % Medicated Liquid SoapSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0363-8280-022020-01-31C16284748780-19d75b9cf-fb3c-f424-e053-dadaa90a57ceDRUG FACTS
0363-8280-042020-01-31C16284748780-19d75b9cf-fb3c-f424-e053-dadaa90a57ceDRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0363-8280-02WELL AT WALGREENS PINK GRAPEFRUIT6 mL in 1 PACKETLIQUID61
0363-8280-04WELL AT WALGREENS PINK GRAPEFRUIT124 mL in 1 TUBELIQUID1241

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0363-8280WELL AT WALGREENS PINK GRAPEFRUIT (SALICYLIC ACID) LIQUID [WALGREEN COMPANY]1Legacy NDC, 2 package rows20151209_60a1e840-58f6-48cb-a997-e133bdc60623.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 31 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0363-82800363-8280-04, 0363-8280-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 30 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB
WATER059QF0KO0RIACT
SODIUM C14-16 OLEFIN SULFONATEO9W3D3YF5UIACT
GLYCERINPDC6A3C0OXIACT
COCAMIDOPROPYL BETAINE5OCF3O11KXIACT
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)74G4R6TH13IACT
SODIUM CHLORIDE451W47IQ8XIACT
HYDROGENATED CASTOR OILZF94AP8MEYIACT
CARRAGEENAN5C69YCD2YJIACT
C12-15 ALKYL LACTATEGC844VRD7EIACT
EDETATE DISODIUM7FLD91C86KIACT
COCAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATEH2KVQ74JM4IACT
PUMMELOET1TN5W71XIACT
POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW)0L414VCS5YIACT
GREEN TEA LEAFW2ZU1RY8B0IACT
ASCORBYL PALMITATEQN83US2B0NIACT
NEOPENTYL GLYCOL DICAPRYLATE/DICAPRATEVLW429K27KIACT
CHAMAEMELUM NOBILE FLOWERO2T154T6OGIACT
POLYSORBATE 207T1F30V5YHIACT
POLYVINYL ALCOHOL532B59J990IACT
PROPYLENE GLYCOL6DC9Q167V3IACT
BUTYLENE GLYCOL3XUS85K0RAIACT
SODIUM BENZOTRIAZOLYL BUTYLPHENOL SULFONATE0LA2QC9O3ZIACT
AGAR89T13OHQ2BIACT
MICAV8A1AW0880IACT
TITANIUM DIOXIDE15FIX9V2JPIACT
SODIUM HYDROXIDE55X04QC32IIACT
D&C RED NO. 302S42T2808BIACT
FD&C RED NO. 40WZB9127XOAIACT
EXT. D&C VIOLET NO. 2G5UX3K0728IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4e91308c-7ee8-42b3-abd4-caf661668db760a1e840-58f6-48cb-a997-e133bdc606232015-12-09WarningsExact identifier
spl id: 4e91308c-7ee8-42b3-abd4-caf661668db7
spl set id: 60a1e840-58f6-48cb-a997-e133bdc60623

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.